International HBV Meeting Program

“Molecular Biology of Hepatitis B Viruses”

Sunday, September 3 – Wednesday, September 6, 2017

Program

Sunday, September 3, 2017       

1 p.m. - Meeting Registration Opens 

6 p.m. - Opening Evening Cheese & Wine Reception Poster Session I -  Viral Entry and New Models, cccDNA and Transcription, Reverse Transcription and Morphogenesis

 

Monday, September 4, 2017       

8:30 a.m. - Welcome Remarks

8:40 a.m. - Session I – Viral Entry and New Models
Chairs: Wenhui Li & Thomas Baumert 

10:40 a.m. - Break

11:00 a.m. - Session II – cccDNA and Transcription
Chairs: 
Maura Dandri & Michael Nassal 

1:00 p.m. - Lunch

2:00 p.m. - Poster Session II - Regulatory Proteins, Viral Pathogenesis, Innate Immune Response, Adaptive Immune Response

3:00 p.m. - Keynote Lecture I:   Hepatitis A Virus (Stanley Lemon, UNC)

3:40 p.m. - Keynote Lecture II:    Hepatitis E Virus (Xiang-Jin Meng, Virginia Tech)

4:20 p.m. - Break

4:40 p.m. - Session III – Reverse Transcription and Morphogenesis
Chairs: Jiaming Hu & John Tavis 

 

Tuesday, September 5, 2017     

8:30 a.m. - Session IV – Regulatory Proteins
Chairs: Ourania Andrisani & Michael Bourchard 

10:30 a.m. - Break

10:45 a.m. - Session V – Viral Pathogenesis
Chairs: Antonio Bertoletti & Dieter Glebe 

12:45 p.m. - Lunch

1:45 p.m. - Poster Session III - Genotypes and Variants, Hepatocellular Carcinoma, Antiviral Therapy

2:45 p.m. - Session VI – Innate Immune Response
Chairs: Barbara Rehermann & Michael Robek 

4:45 p.m. - Break

5:00 p.m. - Session VII – Adaptive Immune Response
Chairs: Adam Gehring & Mala Maini 

 

Wednesday, September 6, 2017

8:30 a.m - Keynote Lecture III:  RNA Biology & Viral Infection (Bryan Cullen, Duke)

9:10 a.m. - Session VIII – Genotypes and Variants
Chairs: Shuping Tong & Teresa Pollicino 

11:10 a.m. - Break                  

11:30 a.m. - Session IX – Hepatocellular Carcinoma
Chairs: James Ou & Patrizia Farci 

1:30 p.m. - Lunch

2:30 p.m. - Session X – Antiviral Therapy
Chairs: Peter Revill & Timothy Block 

6:00 p.m. - Banquet at the National Zoo, Washington, DC

Presentation of the inaugural Distinguished Award in Hepatitis B Research to Dr. Francis Chisari and Poster Awards

 

Thursday, September 7, 2017 - Satellite Symposium

8:30 am – 1 pm   Novel HBV Antiviral and Immune Modulatory Therapies in Preclinical/ Clinical Development

Chairs:  Anna Lok and Marc Ghany 
(please see below for additional information) 

Click Here for to download a PDF of the final program

 

Banquet at the Zoo on Wednesday, September 6

Banquet banner3 4

This year's banquet will be held the evening of Wednesday, September 6 at the Smithsonian’s National Zoo, part of the Smithsonian Institution, the world’s largest museum and research complex. Founded in 1889, the Zoo sits on 163 acres in the heart of Washington, D.C.’s Rock Creek Park and is home to more than 1,500 animals across 300 different species. The zoo is just a short walk from the Omni Shoreham Hotel.  Please visit www.nationalzoo.si.edu for more information.

 

Satellite Symposium

"New HBV Antiviral and Immune Modulatory Therapies in Late Pre-Clinical/Clinical Development"

Anna Lok, Univ. of Michigan and Marc Ghany, NIH, Program Chairs

Thursday, September 7, 8:15 AM – 12:30 PM
Marriott Waldman Hotel

2660 Woodley Rd NW,
Washington, DC 20008

Description of Symposium: There has been a resurgence in interest in therapy of chronic hepatitis B with the development of novel inhibitors of HBV life cycle and therapies aimed at restoring host immune response to HBV. This symposium will provide an overview of gaps in knowledge of current and future HBV treatment, as well as discussion on endpoints and designs of clinical trials aimed at HBV cure.

Attendees will have a greater understanding of the current status of drug development for chronic HBV infection and the appropriate endpoints to guide early and late phase drug development and they will be aware of the appropriate populations to study novel agents with different mechanisms of action.

Target Audience: Hepatologists, Academic Researchers (basic and clinical), Pharmaceutical and Biotechnology Drug Developers and Regulatory agencies 

Click here for the Satellite Symposium Program

 

If any pharmaceutical and biotech companies are interested in presenting their anti-HBV drugs in late preclinical and clinical pipeline in this Satellite Symposium, please contact info@hbvmeeting.org.

For information on submitting abstracts for either the regular meeting or the Satellite Symposium click here.